Global Protein Therapeutics Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	191 Pages	TechNavio	May, 2024	INF18929976

Best Price Guarantee
Price	from $2,500
Length	191 Pages
Publisher	TechNavio
Published Date	May, 2024
SKU	INF18929976

Global Protein Therapeutics Market 2024-2028

Technavio has been monitoring the protein therapeutics market and is forecast to grow by USD 172.8 bn during 2023-2028, accelerating at a CAGR of 9.47% during the forecast period. Our report on the protein therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increased demand for MABS, development of novel therapies using innovative technologies, and availability of favorable reimbursement policies.

Technavio's protein therapeutics market is segmented as below:

By Product

mAbs
Human insulin
Erythropoeitin
Clotting factors
Others

By Application

Metabolic disorders
Immunologic disorders
Hematological disorders
Cancer
Genetic disorders

By Geography

North America
Europe
Asia
Rest of World (ROW)

This study identifies the continued focus on improvement of protein therapeutics as one of the prime reasons driving the protein therapeutics market growth during the next few years. Also, emergence of bi-specific and multi-specific antibodies and increase in chronic diseases will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the protein therapeutics market covers the following areas:

Protein therapeutics market sizing
Protein therapeutics market forecast
Protein therapeutics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading protein therapeutics market vendors that include AbbVie Inc., Amgen Inc., AstraZeneca Plc, Biocon Ltd., Biogen Inc., Bristol Myers Squibb Co., Celltrion Healthcare Co. Ltd., Creative Biolabs, Eli Lilly and Co., F. Hoffmann La Roche Ltd., Intas Pharmaceuticals Ltd., Ipsen Pharma, Johnson and Johnson Services Inc., LGM Pharma LLC, Midas Pharma GmbH, Novartis AG, Novo Nordisk AS, Pfizer Inc., PV Pharma Healthcare Pvt. Ltd., and Sanofi SA. Also, the protein therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market by Geography; Executive Summary - Chart on Market Segmentation by Product; Executive Summary - Chart on Market Segmentation by Application; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on Global - Market size and forecast 2023-2028 ($ billion); Data Table on Global - Market size and forecast 2023-2028 ($ billion); Chart on Global Market: Year-over-year growth 2023-2028 (%); Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global Protein Therapeutics Market 2018 - 2022; Historic Market Size - Data Table on Global Protein Therapeutics Market 2018 - 2022 ($ billion); 4.2 Product segment analysis 2018 - 2022; Historic Market Size - Product Segment 2018 - 2022 ($ billion); 4.3 Application segment analysis 2018 - 2022; Historic Market Size - Application Segment 2018 - 2022 ($ billion); 4.4 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ billion); 4.5 Country segment analysis 2018 - 2022; Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Product: 6.1 Market segments; Chart on Product - Market share 2023-2028 (%); Data Table on Product - Market share 2023-2028 (%); 6.2 Comparison by Product; Chart on Comparison by Product; Data Table on Comparison by Product; 6.3 mAbs - Market size and forecast 2023-2028; Chart on mAbs - Market size and forecast 2023-2028 ($ billion); Data Table on mAbs - Market size and forecast 2023-2028 ($ billion); Chart on mAbs - Year-over-year growth 2023-2028 (%); Data Table on mAbs - Year-over-year growth 2023-2028 (%); 6.4 Human insulin - Market size and forecast 2023-2028; Chart on Human insulin - Market size and forecast 2023-2028 ($ billion); Data Table on Human insulin - Market size and forecast 2023-2028 ($ billion); Chart on Human insulin - Year-over-year growth 2023-2028 (%); Data Table on Human insulin - Year-over-year growth 2023-2028 (%); 6.5 Erythropoeitin - Market size and forecast 2023-2028; Chart on Erythropoeitin - Market size and forecast 2023-2028 ($ billion); Data Table on Erythropoeitin - Market size and forecast 2023-2028 ($ billion); Chart on Erythropoeitin - Year-over-year growth 2023-2028 (%); Data Table on Erythropoeitin - Year-over-year growth 2023-2028 (%); 6.6 Clotting factors - Market size and forecast 2023-2028; Chart on Clotting factors - Market size and forecast 2023-2028 ($ billion); Data Table on Clotting factors - Market size and forecast 2023-2028 ($ billion); Chart on Clotting factors - Year-over-year growth 2023-2028 (%); Data Table on Clotting factors - Year-over-year growth 2023-2028 (%); 6.7 Others - Market size and forecast 2023-2028; Chart on Others - Market size and forecast 2023-2028 ($ billion); Data Table on Others - Market size and forecast 2023-2028 ($ billion); Chart on Others - Year-over-year growth 2023-2028 (%); Data Table on Others - Year-over-year growth 2023-2028 (%); 6.8 Market opportunity by Product; Market opportunity by Product ($ billion); Data Table on Market opportunity by Product ($ billion)
7 Market Segmentation by Application: 7.1 Market segments; Chart on Application - Market share 2023-2028 (%); Data Table on Application - Market share 2023-2028 (%); 7.2 Comparison by Application; Chart on Comparison by Application; Data Table on Comparison by Application; 7.3 Metabolic disorders - Market size and forecast 2023-2028; Chart on Metabolic disorders - Market size and forecast 2023-2028 ($ billion); Data Table on Metabolic disorders - Market size and forecast 2023-2028 ($ billion); Chart on Metabolic disorders - Year-over-year growth 2023-2028 (%); Data Table on Metabolic disorders - Year-over-year growth 2023-2028 (%); 7.4 Immunologic disorders - Market size and forecast 2023-2028; Chart on Immunologic disorders - Market size and forecast 2023-2028 ($ billion); Data Table on Immunologic disorders - Market size and forecast 2023-2028 ($ billion); Chart on Immunologic disorders - Year-over-year growth 2023-2028 (%); Data Table on Immunologic disorders - Year-over-year growth 2023-2028 (%); 7.5 Hematological disorders - Market size and forecast 2023-2028; Chart on Hematological disorders - Market size and forecast 2023-2028 ($ billion); Data Table on Hematological disorders - Market size and forecast 2023-2028 ($ billion); Chart on Hematological disorders - Year-over-year growth 2023-2028 (%); Data Table on Hematological disorders - Year-over-year growth 2023-2028 (%); 7.6 Cancer - Market size and forecast 2023-2028; Chart on Cancer - Market size and forecast 2023-2028 ($ billion); Data Table on Cancer - Market size and forecast 2023-2028 ($ billion); Chart on Cancer - Year-over-year growth 2023-2028 (%); Data Table on Cancer - Year-over-year growth 2023-2028 (%); 7.7 Genetic disorders - Market size and forecast 2023-2028; Chart on Genetic disorders - Market size and forecast 2023-2028 ($ billion); Data Table on Genetic disorders - Market size and forecast 2023-2028 ($ billion); Chart on Genetic disorders - Year-over-year growth 2023-2028 (%); Data Table on Genetic disorders - Year-over-year growth 2023-2028 (%); 7.8 Market opportunity by Application; Market opportunity by Application ($ billion); Data Table on Market opportunity by Application ($ billion)
8 Customer Landscape: 8.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Chart on Market share by geography 2023-2028 (%); Data Table on Market share by geography 2023-2028 (%); 9.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Chart on North America - Market size and forecast 2023-2028 ($ billion); Data Table on North America - Market size and forecast 2023-2028 ($ billion); Chart on North America - Year-over-year growth 2023-2028 (%); Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ billion); Data Table on Europe - Market size and forecast 2023-2028 ($ billion); Chart on Europe - Year-over-year growth 2023-2028 (%); Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Chart on Asia - Market size and forecast 2023-2028 ($ billion); Data Table on Asia - Market size and forecast 2023-2028 ($ billion); Chart on Asia - Year-over-year growth 2023-2028 (%); Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ billion); Data Table on US - Market size and forecast 2023-2028 ($ billion); Chart on US - Year-over-year growth 2023-2028 (%); Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 Canada - Market size and forecast 2023-2028; Chart on Canada - Market size and forecast 2023-2028 ($ billion); Data Table on Canada - Market size and forecast 2023-2028 ($ billion); Chart on Canada - Year-over-year growth 2023-2028 (%); Data Table on Canada - Year-over-year growth 2023-2028 (%); 9.9 Germany - Market size and forecast 2023-2028; Chart on Germany - Market size and forecast 2023-2028 ($ billion); Data Table on Germany - Market size and forecast 2023-2028 ($ billion); Chart on Germany - Year-over-year growth 2023-2028 (%); Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.10 UK - Market size and forecast 2023-2028; Chart on UK - Market size and forecast 2023-2028 ($ billion); Data Table on UK - Market size and forecast 2023-2028 ($ billion); Chart on UK - Year-over-year growth 2023-2028 (%); Data Table on UK - Year-over-year growth 2023-2028 (%); 9.11 China - Market size and forecast 2023-2028; Chart on China - Market size and forecast 2023-2028 ($ billion); Data Table on China - Market size and forecast 2023-2028 ($ billion); Chart on China - Year-over-year growth 2023-2028 (%); Data Table on China - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity by geography; Market opportunity by geography ($ billion); Data Tables on Market opportunity by geography ($ billion)
10 Drivers, Challenges, and Opportunity/Restraints: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 10.4 Market opportunities/restraints
11 Competitive Landscape: 11.1 Overview; 11.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 11.3 Landscape disruption; Overview on factors of disruption; 11.4 Industry risks; Impact of key risks on business
12 Competitive Analysis: 12.1 Companies profiled; Companies covered; 12.2 Market positioning of companies; Matrix on companies position and classification; 12.3 AbbVie Inc.; AbbVie Inc. - Overview; AbbVie Inc. - Product / Service; AbbVie Inc. - Key news; AbbVie Inc. - Key offerings; 12.4 Amgen Inc.; Amgen Inc. - Overview; Amgen Inc. - Product / Service; Amgen Inc. - Key offerings; 12.5 AstraZeneca Plc; AstraZeneca Plc - Overview; AstraZeneca Plc - Product / Service; AstraZeneca Plc - Key news; AstraZeneca Plc - Key offerings; 12.6 Biogen Inc.; Biogen Inc. - Overview; Biogen Inc. - Product / Service; Biogen Inc. - Key news; Biogen Inc. - Key offerings; 12.7 Bristol Myers Squibb Co.; Bristol Myers Squibb Co. - Overview; Bristol Myers Squibb Co. - Product / Service; Bristol Myers Squibb Co. - Key news; Bristol Myers Squibb Co. - Key offerings; 12.8 Creative Biolabs; Creative Biolabs - Overview; Creative Biolabs - Product / Service; Creative Biolabs - Key offerings; 12.9 Eli Lilly and Co.; Eli Lilly and Co. - Overview; Eli Lilly and Co. - Product / Service; Eli Lilly and Co. - Key news; Eli Lilly and Co. - Key offerings; 12.10 F. Hoffmann La Roche Ltd.; F. Hoffmann La Roche Ltd. - Overview; F. Hoffmann La Roche Ltd. - Business segments; F. Hoffmann La Roche Ltd. - Key news; F. Hoffmann La Roche Ltd. - Key offerings; F. Hoffmann La Roche Ltd. - Segment focus; 12.11 Ipsen Pharma; Ipsen Pharma - Overview; Ipsen Pharma - Business segments; Ipsen Pharma - Key offerings; Ipsen Pharma - Segment focus; 12.12 Johnson and Johnson Services Inc.; Johnson and Johnson Services Inc. - Overview; Johnson and Johnson Services Inc. - Business segments; Johnson and Johnson Services Inc. - Key news; Johnson and Johnson Services Inc. - Key offerings; Johnson and Johnson Services Inc. - Segment focus; 12.13 LGM Pharma LLC; LGM Pharma LLC - Overview; LGM Pharma LLC - Product / Service; LGM Pharma LLC - Key offerings; 12.14 Novartis AG; Novartis AG - Overview; Novartis AG - Business segments; Novartis AG - Key news; Novartis AG - Key offerings; Novartis AG - Segment focus; 12.15 Novo Nordisk AS; Novo Nordisk AS - Overview; Novo Nordisk AS - Business segments; Novo Nordisk AS - Key offerings; Novo Nordisk AS - Segment focus; 12.16 Pfizer Inc.; Pfizer Inc. - Overview; Pfizer Inc. - Product / Service; Pfizer Inc. - Key news; Pfizer Inc. - Key offerings; 12.17 Sanofi SA; Sanofi SA - Overview; Sanofi SA - Business segments; Sanofi SA - Key news; Sanofi SA - Key offerings; Sanofi SA - Segment focus
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 13.3 Currency conversion rates for US$; Currency conversion rates for US$; 13.4 Research methodology; Research methodology; 13.5 Data procurement; Information sources; 13.6 Data validation; Data validation; 13.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 13.8 Data synthesis; Data synthesis; 13.9 market analysis; market analysis; 13.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market by Geography; Exhibits5: Executive Summary - Chart on Market Segmentation by Product; Exhibits6: Executive Summary - Chart on Market Segmentation by Application; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Parent Market; Exhibits11: Data Table on - Parent Market; Exhibits12: Market characteristics analysis; Exhibits13: Value Chain Analysis; Exhibits14: Offerings of companies included in the market definition; Exhibits15: Market segments; Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ billion); Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ billion); Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits20: Historic Market Size - Data Table on Global Protein Therapeutics Market 2018 - 2022 ($ billion); Exhibits21: Historic Market Size - Product Segment 2018 - 2022 ($ billion); Exhibits22: Historic Market Size - Application Segment 2018 - 2022 ($ billion); Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ billion); Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ billion); Exhibits25: Five forces analysis - Comparison between 2023 and 2028; Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits31: Chart on Market condition - Five forces 2023 and 2028; Exhibits32: Chart on Product - Market share 2023-2028 (%); Exhibits33: Data Table on Product - Market share 2023-2028 (%); Exhibits34: Chart on Comparison by Product; Exhibits35: Data Table on Comparison by Product; Exhibits36: Chart on mAbs - Market size and forecast 2023-2028 ($ billion); Exhibits37: Data Table on mAbs - Market size and forecast 2023-2028 ($ billion); Exhibits38: Chart on mAbs - Year-over-year growth 2023-2028 (%); Exhibits39: Data Table on mAbs - Year-over-year growth 2023-2028 (%); Exhibits40: Chart on Human insulin - Market size and forecast 2023-2028 ($ billion); Exhibits41: Data Table on Human insulin - Market size and forecast 2023-2028 ($ billion); Exhibits42: Chart on Human insulin - Year-over-year growth 2023-2028 (%); Exhibits43: Data Table on Human insulin - Year-over-year growth 2023-2028 (%); Exhibits44: Chart on Erythropoeitin - Market size and forecast 2023-2028 ($ billion); Exhibits45: Data Table on Erythropoeitin - Market size and forecast 2023-2028 ($ billion); Exhibits46: Chart on Erythropoeitin - Year-over-year growth 2023-2028 (%); Exhibits47: Data Table on Erythropoeitin - Year-over-year growth 2023-2028 (%); Exhibits48: Chart on Clotting factors - Market size and forecast 2023-2028 ($ billion); Exhibits49: Data Table on Clotting factors - Market size and forecast 2023-2028 ($ billion); Exhibits50: Chart on Clotting factors - Year-over-year growth 2023-2028 (%); Exhibits51: Data Table on Clotting factors - Year-over-year growth 2023-2028 (%); Exhibits52: Chart on Others - Market size and forecast 2023-2028 ($ billion); Exhibits53: Data Table on Others - Market size and forecast 2023-2028 ($ billion); Exhibits54: Chart on Others - Year-over-year growth 2023-2028 (%); Exhibits55: Data Table on Others - Year-over-year growth 2023-2028 (%); Exhibits56: Market opportunity by Product ($ billion); Exhibits57: Data Table on Market opportunity by Product ($ billion); Exhibits58: Chart on Application - Market share 2023-2028 (%); Exhibits59: Data Table on Application - Market share 2023-2028 (%); Exhibits60: Chart on Comparison by Application; Exhibits61: Data Table on Comparison by Application; Exhibits62: Chart on Metabolic disorders - Market size and forecast 2023-2028 ($ billion); Exhibits63: Data Table on Metabolic disorders - Market size and forecast 2023-2028 ($ billion); Exhibits64: Chart on Metabolic disorders - Year-over-year growth 2023-2028 (%); Exhibits65: Data Table on Metabolic disorders - Year-over-year growth 2023-2028 (%); Exhibits66: Chart on Immunologic disorders - Market size and forecast 2023-2028 ($ billion); Exhibits67: Data Table on Immunologic disorders - Market size and forecast 2023-2028 ($ billion); Exhibits68: Chart on Immunologic disorders - Year-over-year growth 2023-2028 (%); Exhibits69: Data Table on Immunologic disorders - Year-over-year growth 2023-2028 (%); Exhibits70: Chart on Hematological disorders - Market size and forecast 2023-2028 ($ billion); Exhibits71: Data Table on Hematological disorders - Market size and forecast 2023-2028 ($ billion); Exhibits72: Chart on Hematological disorders - Year-over-year growth 2023-2028 (%); Exhibits73: Data Table on Hematological disorders - Year-over-year growth 2023-2028 (%); Exhibits74: Chart on Cancer - Market size and forecast 2023-2028 ($ billion); Exhibits75: Data Table on Cancer - Market size and forecast 2023-2028 ($ billion); Exhibits76: Chart on Cancer - Year-over-year growth 2023-2028 (%); Exhibits77: Data Table on Cancer - Year-over-year growth 2023-2028 (%); Exhibits78: Chart on Genetic disorders - Market size and forecast 2023-2028 ($ billion); Exhibits79: Data Table on Genetic disorders - Market size and forecast 2023-2028 ($ billion); Exhibits80: Chart on Genetic disorders - Year-over-year growth 2023-2028 (%); Exhibits81: Data Table on Genetic disorders - Year-over-year growth 2023-2028 (%); Exhibits82: Market opportunity by Application ($ billion); Exhibits83: Data Table on Market opportunity by Application ($ billion); Exhibits84: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits85: Chart on Market share by geography 2023-2028 (%); Exhibits86: Data Table on Market share by geography 2023-2028 (%); Exhibits87: Chart on Geographic comparison; Exhibits88: Data Table on Geographic comparison; Exhibits89: Chart on North America - Market size and forecast 2023-2028 ($ billion); Exhibits90: Data Table on North America - Market size and forecast 2023-2028 ($ billion); Exhibits91: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits92: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits93: Chart on Europe - Market size and forecast 2023-2028 ($ billion); Exhibits94: Data Table on Europe - Market size and forecast 2023-2028 ($ billion); Exhibits95: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits96: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits97: Chart on Asia - Market size and forecast 2023-2028 ($ billion); Exhibits98: Data Table on Asia - Market size and forecast 2023-2028 ($ billion); Exhibits99: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits100: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits101: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Exhibits102: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Exhibits103: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits104: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits105: Chart on US - Market size and forecast 2023-2028 ($ billion); Exhibits106: Data Table on US - Market size and forecast 2023-2028 ($ billion); Exhibits107: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits108: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits109: Chart on Canada - Market size and forecast 2023-2028 ($ billion); Exhibits110: Data Table on Canada - Market size and forecast 2023-2028 ($ billion); Exhibits111: Chart on Canada - Year-over-year growth 2023-2028 (%); Exhibits112: Data Table on Canada - Year-over-year growth 2023-2028 (%); Exhibits113: Chart on Germany - Market size and forecast 2023-2028 ($ billion); Exhibits114: Data Table on Germany - Market size and forecast 2023-2028 ($ billion); Exhibits115: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits116: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits117: Chart on UK - Market size and forecast 2023-2028 ($ billion); Exhibits118: Data Table on UK - Market size and forecast 2023-2028 ($ billion); Exhibits119: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits120: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits121: Chart on China - Market size and forecast 2023-2028 ($ billion); Exhibits122: Data Table on China - Market size and forecast 2023-2028 ($ billion); Exhibits123: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits124: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits125: Market opportunity by geography ($ billion); Exhibits126: Data Tables on Market opportunity by geography ($ billion); Exhibits127: Impact of drivers and challenges in 2023 and 2028; Exhibits128: Overview on criticality of inputs and factors of differentiation; Exhibits129: Overview on factors of disruption; Exhibits130: Impact of key risks on business; Exhibits131: Companies covered; Exhibits132: Matrix on companies position and classification; Exhibits133: AbbVie Inc. - Overview; Exhibits134: AbbVie Inc. - Product / Service; Exhibits135: AbbVie Inc. - Key news; Exhibits136: AbbVie Inc. - Key offerings; Exhibits137: Amgen Inc. - Overview; Exhibits138: Amgen Inc. - Product / Service; Exhibits139: Amgen Inc. - Key offerings; Exhibits140: AstraZeneca Plc - Overview; Exhibits141: AstraZeneca Plc - Product / Service; Exhibits142: AstraZeneca Plc - Key news; Exhibits143: AstraZeneca Plc - Key offerings; Exhibits144: Biogen Inc. - Overview; Exhibits145: Biogen Inc. - Product / Service; Exhibits146: Biogen Inc. - Key news; Exhibits147: Biogen Inc. - Key offerings; Exhibits148: Bristol Myers Squibb Co. - Overview; Exhibits149: Bristol Myers Squibb Co. - Product / Service; Exhibits150: Bristol Myers Squibb Co. - Key news; Exhibits151: Bristol Myers Squibb Co. - Key offerings; Exhibits152: Creative Biolabs - Overview; Exhibits153: Creative Biolabs - Product / Service; Exhibits154: Creative Biolabs - Key offerings; Exhibits155: Eli Lilly and Co. - Overview; Exhibits156: Eli Lilly and Co. - Product / Service; Exhibits157: Eli Lilly and Co. - Key news; Exhibits158: Eli Lilly and Co. - Key offerings; Exhibits159: F. Hoffmann La Roche Ltd. - Overview; Exhibits160: F. Hoffmann La Roche Ltd. - Business segments; Exhibits161: F. Hoffmann La Roche Ltd. - Key news; Exhibits162: F. Hoffmann La Roche Ltd. - Key offerings; Exhibits163: F. Hoffmann La Roche Ltd. - Segment focus; Exhibits164: Ipsen Pharma - Overview; Exhibits165: Ipsen Pharma - Business segments; Exhibits166: Ipsen Pharma - Key offerings; Exhibits167: Ipsen Pharma - Segment focus; Exhibits168: Johnson and Johnson Services Inc. - Overview; Exhibits169: Johnson and Johnson Services Inc. - Business segments; Exhibits170: Johnson and Johnson Services Inc. - Key news; Exhibits171: Johnson and Johnson Services Inc. - Key offerings; Exhibits172: Johnson and Johnson Services Inc. - Segment focus; Exhibits173: LGM Pharma LLC - Overview; Exhibits174: LGM Pharma LLC - Product / Service; Exhibits175: LGM Pharma LLC - Key offerings; Exhibits176: Novartis AG - Overview; Exhibits177: Novartis AG - Business segments; Exhibits178: Novartis AG - Key news; Exhibits179: Novartis AG - Key offerings; Exhibits180: Novartis AG - Segment focus; Exhibits181: Novo Nordisk AS - Overview; Exhibits182: Novo Nordisk AS - Business segments; Exhibits183: Novo Nordisk AS - Key offerings; Exhibits184: Novo Nordisk AS - Segment focus; Exhibits185: Pfizer Inc. - Overview; Exhibits186: Pfizer Inc. - Product / Service; Exhibits187: Pfizer Inc. - Key news; Exhibits188: Pfizer Inc. - Key offerings; Exhibits189: Sanofi SA - Overview; Exhibits190: Sanofi SA - Business segments; Exhibits191: Sanofi SA - Key news; Exhibits192: Sanofi SA - Key offerings; Exhibits193: Sanofi SA - Segment focus; Exhibits194: Inclusions checklist; Exhibits195: Exclusions checklist; Exhibits196: Currency conversion rates for US$; Exhibits197: Research methodology; Exhibits198: Information sources; Exhibits199: Data validation; Exhibits200: Validation techniques employed for market sizing; Exhibits201: Data synthesis; Exhibits202: 360 degree market analysis; Exhibits203: List of abbreviations